Krystal Biotech KRYS
NASDAQ KRYS
$322.17 -3.25 (-1.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Krystal Biotech (KRYS) Total Debt (2016)

Updated

Krystal Biotech's Total Debt came in at $698,000 for Q4 2016.

Analysis

Krystal Biotech (KRYS) Total Debt (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Krystal Biotech 9.52 Bn 6.29 Bn 112.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 698,000.00
API Access

Krystal Biotech Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=KRYS&period=max&api_key=YOUR_API_KEY